---
$id: https://graph.org.ai/products/commodity/51161564
$type: Product
source: UNSPSC
code: "51161564"
title: "Ablukast sodium"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ablukast sodium

**UNSPSC Code**: 51161564
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C28H33O8.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 37BXZ0J2RT, chemically known as 2h-1-benzopyran-2-carboxylic acid, 6-acetyl-7-((5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl)oxy)-3,4-dihydro-, monosodium salt, ( -); but more generally known as ablukast sodium, which bears US NIH Compound Identifier 57108. Most nations, for tariff and trade purposes, schedule ablukast sodium under HS 29329985 and SITC 51569. As of Q4 2014, ABLUKAST SODIUM remains US FDA's Preferred Term for this commodity. Ablukast sodium bears US NLM identifiers UMLS ID C2827073 and NCI Concept Code C83514. SMILES: CCCC1C(CCC(C1O)C(=O)C)OCCCCCOC2CC3C(CC2C(=O)C)CCC(O3)C(=O)[O-].[NA+].

